Health Benefits
What the research supports.
EPA · DHA
The health benefits of omega-3.
EPA and DHA are the long-chain omega-3 fatty acids at the core of the marine oil market. Four claims are EFSA-authorised under EC No 1924/2006, the regulatory standard for finished supplement labelling in the EU. Two further callouts reflect peer-reviewed research and are labelled accordingly. Conditions of use apply.
Brain Function
DHA contributes to the maintenance of normal brain function.
Triglycerides
EPA + DHA contribute to maintenance of normal blood triglyceride levels.
Joints
A meta-analysis of 9 RCTs found omega-3 supplementation significantly relieves pain and improves joint function in osteoarthritis patients.
EFSA-Authorised Claims
Peer-Reviewed Research · Not EFSA-Authorised
EFSA Register · EC No 1924/2006 · Health claims subject to conditions of use
Cetoleic acid · Emerging science
Omega-11: herring's edge.
Cetoleic acid occurs at significant concentrations in Norwegian herring, a level rarely found in other marine oils. The research below is peer-reviewed but pre-EFSA: directional science that supplement brands can cite as a differentiator, not yet as an authorised claim.
Cardiovascular Markers
Early studies link cetoleic acid intake to favourable cardiovascular markers.
Lipid Metabolism
Research suggests cetoleic acid may support hepatic lipid handling.
Refs · Frontiers in Nutrition · British Journal of Nutrition · No EFSA-authorised claim
Regulatory framing
What the research shows
Arctic Nutra supplies premium marine oils to supplement brands and contract manufacturers worldwide. We support our customers with high-quality ingredients, technical documentation, and scientific expertise to help develop products for global markets. Any health claims associated with finished products remain the responsibility of the brand owner and must comply with applicable regulations.
Common questions
About the claims.
Are these claims approved by EFSA?
The EPA and DHA statements reflect health claims authorised under EU Regulation (EC) No 1924/2006, with their specified conditions of use (for example, normal heart function at 250 mg EPA+DHA per day). The cetoleic acid (omega-11) research is emerging and carries no EFSA-authorised claim.
Does Arctic Nutra make health claims about its oils?
Arctic Nutra supplies premium marine oils to brands and manufacturers worldwide. The information presented here reflects scientific research on the EPA and DHA naturally present in our oils. Any health claims associated with finished products remain the responsibility of the brand owner and applicable regulations.
How much EPA and DHA does the research reference?
EFSA-authorised claims specify intakes: 250 mg EPA+DHA per day for normal heart function, 250 mg DHA per day for brain and vision, and higher intakes (2 g/day for blood triglycerides, 3 g/day for blood pressure). These are conditions of use for finished products, not properties of the bulk oil.
What does the research suggest about cetoleic acid?
Cetoleic acid (omega-11) is an emerging research area; published work in journals including Frontiers in Nutrition and the British Journal of Nutrition has examined its metabolism. The evidence is early and carries no EFSA-authorised health claim. We describe it as what research suggests, not as proven.
Last reviewed
Build your formulation on documented science.
Response within 1 business day · Sample lead time 5 days